Explore more publications!

Press Releases

Public Health Action Network Is A Partnering Organization for the  'Healthy Indoor Air' Event at the UN General Assembly
WHO cautions of increase of chikungunya disease

WHO cautions of increase of chikungunya disease

Valneva Reports Full Year 2025 Audited Consolidated Financial Results
Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly
Hypersanté Hosts First Francophone Summit on Longevity and Biohacking in Paris
Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities
Pakistan Leads 2025 Global Pollution Rankings

Pakistan Leads 2025 Global Pollution Rankings

Valneva Provides Update on Recommendations for Use of IXCHIQ® in the United Kingdom
Grand Park Kodhipparu Launches ‘Island Celebrations: EID – Connect in Paradise’
Hypersante Introduces the 2026 Longevity and Biohacking Summit in Paris
Valneva Reports Nine-Month 2025 Financial Results and Provides Corporate Updates
GBSA connects Pangyo’s innovative companies with global media outlets through the 2025 Pangyo Global Media Meet-Up
TGR Foundation Celebrates 20 Years of Impact Through Education at TGR Learning Lab in Anaheim
Valneva Reports Half Year 2025 Financial Results and Provides Corporate Updates
WHO cautions against increase of chikungunya illness

WHO cautions against increase of chikungunya illness

WHO Cautions Chikungunya Spread Threatens Billions

WHO Cautions Chikungunya Spread Threatens Billions

OSE Immunotherapeutics Board Urges Support for Value-Driving Strategy and Open-Minded Governance -  Publication of Circular for Combined Annual General Meeting of  September 30, 2025
Valneva Announces FDA’s Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S.
Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information
Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions